Ventus Therapeutics
John is an Investment Director at SoftBank Vision Fund 2, focused on life sciences and health tech. Before joining SBIA, he was an investor at biotech venture firm Arix Bioscience and a consultant in the life sciences practice of L.E.K. Consulting. John has a PhD in Neuroscience from University College London, a BSc in Biochemistry from Imperial College London and has published scientific articles in PNAS, Nature Communications, the Journal of Neuroscience, and eLife.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Ventus Therapeutics
1 followers
Ventus Therapeutics is advancing the next frontier for structure-based drug design to navigate elusive targets, in Montreal and Waltham, MA.